Preferred Label : porphobilinogen synthase;

MeSH definition : An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.;

MeSH synonym : acid dehydratase, delta-aminolevulinic; aminolevulinate hydro-lyase; aminolevulinic acid dehydratase; dehydratase, aminolevulinic acid; delta aminolevulinate dehydratase; delta aminolevulinic acid dehydratase; hydro-lyase, aminolevulinate; synthase, porphobilinogen; aminolevulinate hydro lyase; delta-aminolevulinate dehydratase; dehydratase, delta-aminolevulinate; delta-aminolevulinic acid dehydratase; dehydratase, delta-aminolevulinic acid; ala-dehydrase; ala dehydrase; acid dehydratase, aminolevulinic;

MeSH CAS label : 5-Aminolevulinate hydro-lyase (adding 5-aminolevulinate and cyclizing);

MeSH Related Number : 9036-37-7 (CAS RN);

Registry Number MeSH : EC 4.2.1.24;

MeSH annotation : DF: ALA DEHYDRASE;

Wikipedia link : https://en.wikipedia.org/wiki/Porphobilinogen synthase;

Is substance : O;

UNII : EC 4.2.1.24;

Details


Main resources

You can consult :

An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.

https://www.has-sante.fr/jcms/p_3258964/fr/givlaari
2021
false
false
false
France
Givosiran
givosiran
acetylgalactosamine
pyrrolidines
insurance, health, reimbursement
adult
porphyria, acute hepatic
injections, subcutaneous
evaluation of the transparency committee
porphyrias, hepatic
porphobilinogen synthase
porphobilinogen synthase
givosiran

---
https://www.ema.europa.eu/en/medicines/human/EPAR/givlaari
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
acute disease
porphyrias, hepatic
drug approval
europe
product surveillance, postmarketing
adult
adolescent
injections, subcutaneous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
porphyria, acute hepatic
givosiran
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran

---
https://www.has-sante.fr/jcms/p_3191915/fr/givlaari
2020
false
false
false
France
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
givosiran
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
porphyrias, hepatic
acute disease
porphyria, acute hepatic
guidelines for drug use
continuity of patient care
evaluation of the transparency committee
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.